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ABSTRACT: Mild oxidation of bromides by iodine(III) reagents 
generated active electrophilic bromination species that were re-
acted with polyprenoids. By simple and minor variations of an 
I(III)/Br combination the reactivity could be selectively steered to-
ward dibromination, oxybromination or bromocyclization, giving 
access to a wide array of brominated motifs. 
Brominated terpenoids of marine origin constitute a particularly 
wide class of natural products that exhibit a vast array of structural 
diversity1 and potential therapeutic applications.2 A myriad of mo-
tifs, arising from diverse biosynthetic pathways,3 can be found in 
different families and sometimes in the same molecule. For exam-
ple, just considering the brominated moieties of the bromophy-
colide A4 macrocycle (1, Figure 1), fragments arising from a car-
bobromination, a hydroxybromination and an acyloxybromination 
(with the opposite regiochemistry) of a geranyl-geranyl chain can 
be delineated. A carbobromination accounts for the formation of 
cyclocymopol 25 but in this case the double bond lies out of the 
ring. Isocymobarbatol 36 stems from the same linear precursor but 
through a formal cascade cyclization, resulting in a tricyclic scaf-
fold. This variability could be explained by the intermediacy of one 
or several halogenating enzymes,3 but raises complex chemo-, re-
gio- and stereoselectivity issues, which remain challenging for or-
ganic chemists. One way to address this challenge is to design spe-
cific reagents for one transformation, as shown by Snyder with the 
development of bromocyclization specific BDSB reagent.7,8 
 
Figure 1 Examples of brominated terpenoids of marine origin. 
For our part we thought that it would be highly desirable to de-
sign a general strategy that would demand only limited modifica-
tions of the modus operandi to completely deviate the reactivity in 
one or another chemical direction. Based on our previous experi-
ence9 with iodine(III)-mediated bromination reactions10 we be-
lieved that when generating the active bromination species by in 
situ oxidation of a bromide by a hypervalent iodine(III) species11 
several parameters would be easily tunable so as to govern the se-
lectivity of the reaction. Thus, running the reaction in a non-partic-
ipating solvent in the absence of external nucleophile should favor 
bromocyclization9d towards bromocyclohexenyl 5 (Scheme 1, eq 
1), while adding an alcohol to the reaction mixture would trigger 
an oxybromination9a towards alkyl-bromohydrine 6 (Scheme 1, eq 
2). 
Scheme 1 Chemoselective iodine(III)-mediated bromination 
of a geranyl derivative. 
 
Initial experiments were performed on geranyl acetate 4a using 
a combination of (diacetoxyiodo)benzene (DIB) and lithium bro-
mide in acetonitrile, which led to dibromo derivative 7a with 91% 
yield (Scheme 2). Running the same reaction in ethanol or in a wa-
ter/acetonitrile mixture triggered the oxybromination process yield-
ing ethoxy- and hydroxy adducts 6a and 6a’, respectively, with sat-
isfying yields. This reactivity switch validated the second half of 
our premise but despite extensive screening,12 geranyl acetate, be-
cause of the deactivation of the internal double bond, seemed un-
suitable to probe the triggering of the cyclization process. 
Scheme 2 Solvent effect in the DIB-mediated bromination 
of geranyl acetate. 
 
In order to circumvent this hurdle, we decided to focus our at-
tention on the reactivity of the electron-rich homogeranylbenzene 
4b (Table 1), that has been shown to cyclize more readily towards 
mono- (5b) and/or tricyclic (8b) adducts under a variety of condi-
tions.7,8  
 Table 1 Optimization of the iodine(III)-mediated dibromination, oxybromination and bromocyclization of homogeranylben-
zene 4b.a 
 
entry R (x equiv) M (y equiv) solvent [M]b temp 
addition  
time 
5b,  
yield %c 
6b,  
yield % c 
7b,  
yield % c 
8b,  
yield %c 
1 Ac (1.2) Li (2.4) MeCN 0.05 0 °C 5 mind - - 63 - 
2 Ac (1.1) Li (1.1) MeCN 0.02 0 °C 10 min - - 46 - 
3 C(O)CF3 (1.2) Li (1.1) MeCN 0.01 0 °C 30 min 17 - -e 22 
4 C(O)CF3 (1.2) Me3Si (1.1) MeCN 0.01 0 °C 20 min 41 - Tracesf 15(46) 
5 C(O)CF3 (1.2) Me3Si (1.1) MeCN 0.01 0 °C 30 min 16 - 3f 19g 
6 C(O)CF3 (1.2 Et3Si (1.1) MeCN 0.01 0 °C 20 min 33 - -f 15g 
7 C(O)CF3 (1.2) Et3HN (1.1) MeCN 0.01 0 °C 10 min 15 6 - f 20 
8 C(O)CF3 (1.2) Bu4N (1.1) MeCN 0.01 0 °C 10 min 6 44 -f 8 
9 C(O)CF3 (1.2) Bu4N (1.1) MeCN 0.04 0 °C 5 min - 60 - - 
10 C(O)CF3 (1.2) Et3Si (1.1) MeNO2 0.01 0 °C 10 min 27 4 -f 20 
11 C(O)CMe3 (1.2) Et3Si (1.1) MeNO2 0.01 0 °C 10 min 24 - -f 24 
12 C(O)CMe3 (1.2) Et3Si (1.1) EtNO2 0.04 –78 °C 10 min N/Ah - - (54) 
13 C(O)CMe3 (1.2) Et3Si (1.1) EtNO2 0.04 –78 °C 10 min N/Ah - - (67)i 
aA solution of MBr [2C] was slowly added to a solution of 4b [2C] containing the iodine(III) reagent. bResulting concentration after 
addition. cIsolated yields; for 8b overall yield after re-cyclization of 5b with ClSO3H is given in parenthesis. dDirect addition of LiBr and 
with 4 Å MS. eAnd 7% of 10b. fAnd traces of 10b. gAnd 8% of 11b. hThe crude reaction mixture (5:2:1 ratio of tetra-, tri-, disubstituted 
olefins) was recyclized without purification. iRecyclization with MeSO3H, dr = 6:1. 
We therefore screened numerous parameters12 in order to gener-
ate the initial bromonium intermediate 9b and selectively orientate 
its evolutions towards one of the many possible adducts (5-8, 10 
and 11).13 As with geranyl acetate, the combination of DIB and 
LiBr in MeCN, mainly led to dibromo compound 7b in 63% yield 
(Table 1, entry 1).14 Halving the amount of bromide and adding it 
slowly as the last reagent in order to prevent dibromination only led 
to a decrease in yield, without changing the reaction course (Table 
1, entry 2). However, using this protocol and replacing the DIB by 
its trifluoroacetoxy analog (PIFA) diverted the reactivity toward 
bromocyclization giving 5b (as a mixture of isomers) and tricycle 
8b in a 39% cumulated yield (Table 1, entry 3). This result could 
be further improved by using the more soluble TMSBr to give 41% 
of 5b and 15% of 8b (Table 1, entry 4). Treatment of the mixture 
of brominated cyclohexenes 5b with chlorosulfonic acid in 2-nitro-
propane at – 78°C7,8 to give 8b led to a cumulated yield of tricyclic 
adduct of 46%. Increasing the addition time (Table 1, entry 5) or 
exchanging trimethylsilylbromide for triethylsilylbromide (Table 
1, entry 6) mostly led to complex mixtures of adducts, including 
allylbromide 10b and cyclopentene 11b.13 When alkylammonium 
bromide salts were used, the acyloxybromination pathway was also 
observed (Table 1, entries 7 and 8), with 6b becoming the major 
product when tetrabutylammonium bromide was employed (Table 
1, entry 8). This could be further improved by increasing slightly 
the concentration and the addition rate, to obtain 60% of 6b (Table 
1, entry 9). Running the reaction in nitromethane with TESBr 
steered the reactivity back towards cyclization (Table 1, entry 10) 
and using the bulkier bis(tert-butylcarbonyloxy)iodobenzene com-
pletely suppressed the oxybromination pathway (Table 1, entry 11). 
In order to perform the reaction at a lower temperature (– 78 °C), 
nitroethane was employed instead of nitromethane. This prevented 
the formation of 10b and directly submitting the crude product to 
ClSO3H treatment gave 8b in 54% yield over two steps (Table 1, 
entry 12). Eventually, performing the same sequence with MeSO3H 
in the second step improved the yield up to 67% in a 6:1 diastereo-
meric ratio (Table 1, entry 13).15 This thorough optimization helped 
define three sets of conditions to selectively access dibromo- ox-
ybromo- and cyclobromo-derivatives. First, the scope of the former 
two processes was evaluated. 
In addition to the above mentioned results on geranyl acetate 4a 
and homogeranylbenzene 4b, the combination of DIB and LiBr se-
lectively triggered the dibromination of o-homogeranylanisole 4c 
and geranylbenzene 4d to give 7a–d in good to excellent yields 
(Table 2, entries 1–4). The same protocol could be applied to gera-
niol 4e to give 7e in 63% yield without any detectable oxidation of 
the free alcohol (Table 2, entry 5). Finally, the more challenging 
bis(benzyloxycarbamate)-guanidine 4f could be selectively dibro-
minated to yield 7f by using a reverse addition protocol at –78 °C 
(Table 2, entry 6). The same substrates were also submitted to the 
PIFA/n-Bu4NBr combination to give the α-bromo trifluoroacetyl 
adducts 6. Geranyl acetate led to 6a’’ and geraniol to 6e in 77% and 
 57% yield, respectively (Table 2, entries 1 and 5). In addition to 4b, 
the other aryl derivatives 4c and 4d reacted equally well to give the 
oxybrominated adducts in 56% and 64% yield (Table 2, entries 3 
and 4). Only guanidine 4f reacted sluggishly to yield the desired 
trifluoroacetoxy adduct 6f in only 25% yield (Table 2, entry 6) 
along with 13% of 7f and 31% of cyclic guanidine 12 (see Scheme 
5). Finally, it was demonstrated that selective cleavage of the tri-
fluoroacetoxy group of 6b could be achieved with NaBH4 to give 
the corresponding bromohydrine with 79% yield.12 
Table 2 Scope of the dibromination and the trifluoroace-
toxybromination. 
 
entry 4, R  7, yield %a  6, yield %b 
1 4a,  OAc 91 77 
2 4b, Bn 63 60 
3 4c, o-MeOBn 52 56 
4 4d, Ph 55 64 
5 4, OHe 63 57 
6 4f, NHC(NZ)NHZ  52c 25d 
aIsolated yields for conditions A: PhI(OAc)2 (1.2 equiv), LiBr 
(2.4 equiv), 4 Å MS in MeCN, at 0 °C for 5 min bIsolated yields 
for conditions B: PhI(OCOCF3)2 (1.2 equiv) n-Bu4NBr (2.4 
equiv) in MeCN, at 0 °C for 5 min cAt –78 °C, using TESBr 
instead of LiBr. dAt –78 °C, + 13 % of 6f and 31% of 12. 
 
We then turned our attention towards the third protocol and stud-
ied the cyclization of several homogeranyl and geranyl derivatives. 
First, homogeranylarenes were reacted under the optimized condi-
tions, followed by treatment with sulfonic acid or with tin(IV) chlo-
ride,15 to provide the corresponding tricycles (Scheme 3). Para-tol-
uene 4g, para-anisole 4h and ortho-anisole 4c derivatives led to the 
desired bromo-octahydrophenanthrenes 8g, 8h and 8c with 40% to 
60% yields and moderate to good diastereoselectivities.  
Scheme 3 Bromocyclization of homogeranyl- and 
homofarnesylarenes. 
 
The reaction proceeded even better with meta-anisyl substrate 4i, 
although the two adducts arising from para and ortho addition (8i 
+ 8i’ = 73% yield) were formed. Finally, homofarnesylbenzene 4j 
was reacted to give bromotetracycle 8j in a low but satisfying yield, 
considering that one C-Br and three C-C bonds are formed in the 
sequence. 
In the case of phenolic homogeranyl derivatives, PhI(OPiv)2-me-
diated bromocyclization gave good (59% to 65%) overall yield of 
bromo-cyclized products,16 the distribution of which varied de-
pending on the initial substitution pattern (Scheme 4). Starting from 
ortho-phenol 4k, in addition to the monocyclic cyclohexenes 5k 
and the expected tricycle 8k, compound 13 embedding a seven-
membered ring was also isolated.17 For meta-phenol 4l, the cyclo-
hexenes 5l were obtained in 36% yield and the two brominated pol-
ycycles arising from para and ortho addition (8l + 8l’ = 23% yield) 
were also formed. 
Scheme 4 Bromocyclization of homogeranylphenols. 
 
Finally, the behavior of geranyl compounds was explored 
(Scheme 5). Geranyl-benzene 4d led to bromocyclohexenes 5d in 
43% yield as a mixture of endo/exo adducts.18 The analogous cy-
clohexenes 5m were obtained in slightly higher yield (51%) from 
o-geranylanisole 4m along with 24% of bromo-hexahydroxanthene 
14 arising from a cascade cyclization and concomitant loss of a me-
thyl group. 
Scheme 5 Bromocyclization of geranyl derivatives. 
 
 As could be expected, this isocymobarbatol-like adduct became 
the major product when o-geranylphenol 4n was subjected to the 
PhI(OPiv)2/TESBr combination. 3-Bromochromane 15, resulting 
from a phenoxybromination of the internal double bond, was also 
observed as a minor adduct. This change in chemoselectivity might 
hint at an active participation of the heteroatom in the cyclization 
process, presumably via initial ligand exchange between the phenol 
and the ester on the hypervalent iodine center, followed by oxy-
halogenation of the proximal double bond. This was further exem-
plified by the reaction of guanidine 4f which smoothly led to 12 
with 75% yield. Indeed, it is the only substrate that we studied for 
which the reaction mainly occurred on the internal double bond. 
Overall we have shown that using a combination of a 
(bisacyloxy)iodobenzene and a bromide source three different elec-
trophilic brominations of terpenoids with different outcomes could 
be triggered. Simple adjustments in the nature of the reagents (all 
commercially available) and the procedure (temperature, rate and 
order of addition) could steer the reactivity towards dibromination, 
oxy-bromination or bromocyclization, including cascade pro-
cesses. This strategy grants access to various motifs that can be 
found in several families of natural products. Studies in this direc-
tion as well as the implementation of this methodology for other 
halides are currently being pursued. 
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